T 0749/94 (Erythropoietin/GENETICS INSTITUTE) of 21.04.1997
- European Case Law Identifier
- ECLI:EP:BA:1997:T074994.19970421
- Date of decision
- 21 April 1997
- Case number
- T 0749/94
- Petition for review of
- -
- Application number
- 86900400.2
- IPC class
- C07K 7/10
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Homogeneous Erythropoietin
- Applicant name
- Genetics Institute, Inc.
- Opponent name
- Janssen-Cilag GmbH
Kirin-Amgen Inc. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2) 1973European Patent Convention Art 52(1) 1973European Patent Convention Art 57 1973European Patent Convention Art 84 1973
- Keywords
- Not susceptible of industrial application - new ground of opposition not considered
Main request - added subject-matter (yes)
First, second and third auxiliary requests - clarity (no) - Catchword
- To assess whether the requirements of Article 123(2) are fulfilled it may be necessary if the application as filed does not contain an expressis verbis disclosure of the amendment introduced into the claim to examine in a first step whether the subject-matter of the amended claim fulfils the requirements of Article 84 EPC.
- Citing cases
- T 0364/97
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.